1,755
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

The use of PRO in adverse event identification during cancer therapy – choosing the right questions to ask

, &
Pages 596-602 | Received 23 Jul 2018, Accepted 04 Dec 2018, Published online: 31 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Dag Rune Stormoen, Gry Assam Taarnhøj, Rasmus Blechingberg Friis, Christoffer Johansen & Helle Pappot. (2023) Association of patient-reported pain with survival in bladder cancer: a post-hoc analysis of the iBLAD trial. Acta Oncologica 62:7, pages 814-819.
Read now
Mille Guldager Christiansen, Mary Jarden, Louise Bager, Mansoor Raza Mirza, Helle Pappot & Karin Piil. (2022) SystematiC nurse-led cONsultations based oN Electronic patient-reported outcome among women with ovarian- or endometrial Cancer during chemoTherapy – protocol for the CONNECT study. Acta Oncologica 61:5, pages 602-607.
Read now
Helle Pappot & Gry Assam Taarnhøj. (2020) Expectations to Patient-Reported Outcome (PRO) in Oncology – PRO for a purpose, when and how?. Acta Oncologica 59:6, pages 611-612.
Read now
Susanne Oksbjerg Dalton & Christoffer Johansen. (2019) European cancer rehabilitation and survivorship, 2018: one of a kind. Acta Oncologica 58:5, pages 519-521.
Read now

Articles from other publishers (11)

Gry Assam Taarnhøj, Christoffer Johansen, Andreas Carus, Rikke Hedegaard Dahlrot, Line Hammer Dohn, Niels Henrik Hjøllund, Mark Bech Knudsen, Anders Tolver, Henriette Lindberg & Helle Pappot. (2023) The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial. Journal of Patient-Reported Outcomes 7:1.
Crossref
Mille Guldager Christiansen, Helle Pappot, Pernille Tine Jensen, Mansoor Raza Mirza, Mary Jarden & Karin Piil. (2023) A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy. Journal of Patient-Reported Outcomes 7:1.
Crossref
Ida Marie Lind Rasmussen, Anne Vest Soerensen, Anne Kirstine Møller, Gitte Fredberg Persson, Jesper Andreas Palshof, Gry Assam Taarnhøj & Helle Pappot. (2022) Individualizing the Oncological Treatment of Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma by Using Gene Sequencing and Patient-Reported Outcomes: Protocol for the INDIGO Study. JMIR Research Protocols 11:9, pages e36632.
Crossref
Rogini Balachandran, Louise Zinck Mogensen, Peter Christensen, Henriette Vind Thaysen & Lene Hjerrild Iversen. (2022) Organ-Specific Adverse Effects After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Annals of Surgical Oncology 29:9, pages 6049-6083.
Crossref
P. K. Møller, H. Pappot, U. Bernchou, T. Schytte & K. B. Dieperink. (2021) Development of patient-reported outcomes item set to evaluate acute treatment toxicity to pelvic online magnetic resonance-guided radiotherapy. Journal of Patient-Reported Outcomes 5:1.
Crossref
A. L. Slade, A. Retzer, K. Ahmed, D. Kyte, T. Keeley, J. Armes, J. M. Brown, L. Calman, A. Gavin, A. W. Glaser, D. M. Greenfield, A. Lanceley, R. M. Taylor, G. Velikova, G. Turner & M. J. Calvert. (2021) Systematic review of the use of translated patient-reported outcome measures in cancer trials. Trials 22:1.
Crossref
André Manuel Da Silva Lopes, Sara Colomer-Lahiguera, Nuria Mederos Alfonso, Veronica Aedo-Lopez, Gilliosa Spurrier-Bernard, Lærke Kjær Tolstrup, Helle Pappot, Sandrine Aspeslagh, Anne Rogiers, Bart Neyns, John B. Haanen, Sandra A. Mitchell, Alfredo Addeo, Olivier Michielin & Manuela Eicher. (2021) Patient-reported outcomes for monitoring symptomatic toxicities in cancer patients treated with immune-checkpoint inhibitors: A Delphi study. European Journal of Cancer 157, pages 225-237.
Crossref
Evalien Veldhuijzen, Iris Walraven & José Belderbos. (2021) Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study. JMIR Cancer 7:3, pages e26574.
Crossref
Gry A. Taarnhøj, Christoffer Johansen, Henriette Lindberg, Ethan Basch, Amylou Dueck & Helle Pappot. (2020) Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease. Cancer Medicine 9:9, pages 3078-3087.
Crossref
Gry Assam Taarnhøj, Henriette Lindberg, Christoffer Johansen & Helle Pappot. (2019) Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy. Journal of Patient-Reported Outcomes 3:1.
Crossref
Lærke K. Tolstrup, Lars Bastholt, Ann-Dorthe Zwisler, Karin B. Dieperink & Helle Pappot. (2019) Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy. Journal of Patient-Reported Outcomes 3:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.